Recombinant Monoclonal Antibodies [RecMAbs™] - Produced with No Use of Animals


RecMabs - Non Animal UseAdipoGen Life Sciences (AdipoGen) is a research company developing proteins, biochemicals, antibodies and ELISA Kits. To promote the advancement of non-animal alternative approaches (3Rs), AdipoGen implemented the antibody phage display technology in-house to develop monoclonal antibodies without the use of animals. Using this technology, AdipoGen was a forerunner in releasing the first recombinant monoclonal antibody for research on the market in 2010: anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1). Since then, our portfolio of fully validated recombinant antibodies made with the phage display technology continues to grow, with a focus on functional antibodies that can block or activate their respective target.

Antibody phage display is an in vitro technology to generate recombinant monoclonal antibodies (RecMAbs™) without the use of animals. It is an alternative to the hybridoma technology that circumvents the limitations of the immune system. Antibodies developed by “antibody phage display technology” use human naïve antibody gene libraries. These libraries consist of billions of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are fused to the coat protein pIII and displayed on the surface of filamentous bacteriophages (M13). The scFvs are selected in vitro by affinity selection on the antigen in a process termed panning, where the antigen of interest is coated on a vial (see Figure). Panning methods are based on four major steps: i) preparation of phage-displaying libraries; ii) adsorbing the specific binding phage on an antigen-coated vial, iii) removal of non-specific or low affinity phages, and iv) recovering of target binders that will be reamplified after bacteria infection for the next round of selection. Multiple rounds of panning are performed to enrich the antigen-specific scFv-phages. Monoclonal antibodies are subsequently identified by screening after the last round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.

Antibody SchematicsThere are many advantages to use recombinant antibodies instead of "classical" antibodies: i) no requirement of sacrificing animals in an animal facility; ii) economical production and permanent storage of DNA clones; iii) sequence-defined antibodies allowing reproducibility in experiments; iv) use of a single chain antibody fragment to reformat a RecMAb™ into a full-length IgG construct for research or therapeutic purposes.

 

Binding and FunctionalityAn important attribute of the RecMAbs™ phage display approach is the ability to design selection strategies to generate antibodies with customized functions (FuncAbs™), which furthermore can be classified based on activity or mode of binding. By example, it is possible to generate RecMAbs™ that: (i) preferentially recognize a specific conformational state and thus, have the potential to induce a specified conformational change; (ii) target specific regions of the surface of the target protein (‘‘regio-specific’’) or (iii) specifically recognize multi-protein complexes.


FEATURES OF NON-ANIMAL SOURCE RecMAbs

  • Developed from a human antibody phage display library. 
  • Consists of a scFv (single chain fragment variable) which is composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) fused to a Fc region. 
  • Produced in mammalian cells (CHO or HEK 293). 
  • Similar properties compared to monoclonal antibodies developed in mice/rat (e.g. affinity in the low nanomolar range). 
  • Standard secondary antibodies can be used. 
  • Ideal for conserved antigens (which are poorly immunogenic in animals). 
  • Detect conformational epitopes (e.g. GTP-bound proteins). 
  • Detect protein modifications (e.g. phosphorylations, ubiquitinations). 
  • Allows to exchange the Fc region with Fc from other species.

 



VALIDATED Recombinant Monoclonal Antibodies [RecMAbs™] with No Use of Animals

 

Product Name PID Isotype Applications Species
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1)

AG-27B-0016

Mouse IgG2bλ ELISA, FUNC, ICC Human, Mouse
anti-Angiopoietin-2 (human), mAb (rec.) (blocking) (Angy-1-4) AG-27B-0015 Human IgG2λ ELISA, FUNC Human
anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) AG-27B-0001 Mouse IgG2bλ ELISA, IP, FUNC Mouse
anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-3) AG-27B-0017 Human IgG1λ ELISA, IP, FUNC Mouse
anti-CD30 (human), mAb (rec.) (SH313-B5) AG-27B-6314 Human IgG1  FUNC, ELISA, FACS, ICC, WB Human
anti-Cdh2, mAb (rec.) (SH1352-B11) AG-27B-6315 Human IgG1 ELISA, FACS, IHC, WB Human, Zebrafish
anti-Cdh2 (zebrafish), mAb (rec.) (SH1352-G9) AG-27B-6316 Human IgG1 ELISA, FACS, IHC, WB Zebrafish
anti-Crf2 (Aspergillus fumigatus), mAb (rec.) (MS130h-IIIC2) AG-27B-6317 Human IgG1 ELISA, IF Aspergillus fumigatus
anti-Crf2 (Aspergillus fumigatus), mAb (rec.) (MS112-IIA1) AG-27B-6318 Human IgG1 FUNC, ELISA, IF, IHC, WB Aspergillus fumigatus
anti-Crf2 (Aspergillus fumigatus), mAb (rec.) (MS130i-IIIC3) AG-27B-6319 Human IgG1 ELISA, IF Aspergillus fumigatus
anti-c-Myc, mAb (rec.) (9E10 improved variant, HyperMyc) (Fc Human) AG-27B-6301 Human IgG1 ELISA, ICC, IHC, WB, PEP c-Myc Tag
anti-c-Myc, mAb (rec.) (9E10 improved variant, HyperMyc) (Fc Mouse) AG-27B-6302 Mouse IgG2a ELISA, ICC, IHC, WB, PEP c-Myc Tag
anti-c-Myc, mAb (rec.) (9E10 improved variant, HyperMyc) (Fc Rabbit) AG-27B-6303 Rabbit IgG ELISA, ICC, IHC, WB, PEP c-Myc Tag
anti-CRP (human), mAb (rec.) (SH1177-F3) AG-27B-6320 Human IgG1 ELISA, WB, PEP, QCM Human
anti-CRP (human), mAb (rec.) (TOB5-D4) AG-27B-6321 Human IgG1 ELISA, WB, PEP Human
anti-EGFP, mAb (rec.) (G3) AG-27B-0007 Human IgG2λ ELISA, ICC, IP -
anti-FliD (Pseudomonas aeruginosa), mAb (rec.) (SH1579-B7) AG-27B-6322 Human IgG1 ELISA, WB Pseudomonas aeruginosa
anti-Giantin, mAb (rec.) (TA10) AG-27B-0003 Human IgG2λ ICC Human, Mouse
anti-gp41 (HIV), mAb (rec.) (A2) AG-27B-6323 Human IgG1 ELISA, IP, FACS HIV
anti-Hex1 (Neurospora crassa), mAb (rec.) (SH1237-F8) AG-27B-6324 Human IgG1 ELISA, IGS Neurospora crassa
anti-HMGB1, mAb (rec.) (Giby-1-4)

AG-27B-0002

Human IgG2λ ELISA, WB Human, Mouse, Rat
anti-IL-1R2 (mouse), mAb (rec.) (Praxy-1-1) AG-27B-0011 Mouse IgG2bλ ELISA, FACS Mouse
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) AG-27B-0013 Mouse IgG2b ELISA, FUNC Mouse
anti-IL-33 (mouse), mAb (rec.) (Carly-1-4)

AG-27B-0012

Human IgG2λ ELISA, WB Mouse
anti-Isthmin-1, mAb (rec.) (Giusepi-1-4)

AG-27B-0022

Mouse IgG2bλ ELISA, WB Human, Mouse
UNIQUE  anti-IgG (human), mAb (rec.) Multiclonal AG-27B-6300 Mouse IgG2a ELISA, FACS, IHC, WB Human
UNIQUE  anti-IgG (human), mAb (rec.) Multiclonal (HRP) AG-27B-6300E Mouse IgG2a ELISA, FACS, IHC, WB Human
anti-LPS (Legionella pneumophila), mAb (rec.) (PHK121-H2) AG-27B-6325 Human IgG1 ELISA, WB, VANTIX Legionella pneumophila
anti-LRP5/6, mAb (rec.) (Heldy-1-4) AG-27B-0019 Human IgG2λ FACS Human, Mouse
anti-Myosin IIA (non-muscle) (heavy chain), mAb (rec.) (SF9)

AG-27B-0010

Human IgG2λ EM, ELISA, ICC, IP Drosophila, Human, Mouse, Rat
anti-Netrin-1 (human), mAb (rec.) (blocking) (2F5) (preservative-free)

AG-27B-0018PF

Mouse IgG2λ ELISA, FUNC Human, Mouse
anti-Netrin-1 (human), mAb (rec.) (H4) (preservative-free)

AG-27B-0020PF

Mouse IgG2λ ELISA, FUNC (Negative Control) Human, Mouse
anti-p75NTR (mouse), mAb (rec.) (SH325-G7) AG-27B-6326 Human IgG1 ELISA, FACS, WB Mouse
anti-p75NTR (mouse), mAb (rec.) (SH325-B6) AG-27B-6327 Human IgG1 ELISA, FACS, WB (weak) Mouse
anti-p75NTR (mouse), mAb (rec.) (SH325-A11) AG-27B-6328 Human IgG1 ELISA, FACS, WB (weak) Mouse
anti-PEDF (human), mAb (rec.) (Serpy-1-4)

AG-27B-0014

Human IgG2λ ELISA, WB Human
anti-PSD-95 (palmitoylated), mAb (rec.) (PF11) AG-27B-0021 Human IgG2 ICC, IHC Human, Mouse, Rat
anti-Rab1-GTP, mAb (rec.) (ROF7)

AG-27B-0006

Human IgG2λ ICC, IP Dog, Human, Mouse, Rat
anti-Rab6-GTP, mAb (rec.) (AA2)

AG-27B-0004

Human IgG2λ ICC Drosophila, Human, Mouse
anti-RhoA/B (ADP-ribosylated) (human), mAb (rec.) (VIF140-A1)

AG-27B-6313

Human IgG1 ELISA, ICC, WB Human
anti-SARS-CoV-2 Spike Protein S1 (RBD), mAb (rec.) (Covi-1) (preservative-free) AG-27B-6005PF Human IgG1 ELISA, WB, FUNC (Blocking) SARS-CoV-2 RBD
anti-SARS-CoV-2 Spike Protein S1 (RBD), mAb (rec.) (Covi-2) (preservative-free) AG-27B-6006PF Human IgG1 ELISA, WB, FUNC (Blocking) SARS-CoV-2 RBD
anti-SARS-CoV-2 N Protein, mAb (rec.) (Capsi-1) (preservative free) AG-27B-6007PF Human IgG1 ELISA, Colloidal Gold Immuno-chromatogr. Test SARS-CoV-2 N  Protein
anti-SARS-CoV-2 N Protein, mAb (rec.) (AB75-C03) AG-27B-6304 Mouse IgG2a ELISA, ICC, WB SARS-CoV-2 N Protein
anti-SARS-CoV-2 N Protein, mAb (rec.) (AB79-E11) (Fc Mouse) AG-27B-6305 Mouse IgG2a ELISA, ICC, WB SARS-CoV-2 N Protein
anti-SARS-CoV-2 N Protein, mAb (rec.) (AB83-C12) AG-27B-6306 Mouse IgG2a ELISA, ICC, WB SARS-CoV-2 N Protein
anti-SARS-CoV-2 Spike Protein S1 (NTD), mAb (rec.) (AB72-1-G09) AG-27B-6307 Mouse IgG2a ELISA SARS-CoV-2 Spike S1 N-Terminal Domain Protein
anti-SARS-CoV-2 Spike Protein S1 (NTD), mAb (rec.) (AB72-1-H10) AG-27B-6308 Mouse IgG2a ELISA SARS-CoV-2 Spike S1 N-Terminal Domain Protein
anti-SARS-CoV-2 Spike Protein S1 (RBD), mAb (rec.) (AB65-3-G12) AG-27B-6309 Mouse IgG2a ELISA SARS-CoV-2 RBD
anti-SARS-CoV-2 Spike Protein S1 (RBD), mAb (rec.) (AB68-A09) (Fc Human) AG-27B-6310 Human IgG1 ELISA, ICC, WB SARS-CoV-2 RBD
anti-SARS-CoV-2 Spike Protein S1 (RBD), mAb (rec.) (AB68-A09) (Fc Mouse) AG-27B-6311 Mouse IgG2a ELISA, ICC, WB SARS-CoV-2 RBD
anti-SARS-CoV-2 Spike Protein S1 (SD2), mAb (rec.) (AB66-6-C10) AG-27B-6312 Mouse IgG2a ELISA, ICC, WB SARS-CoV-2 Spike S1 Subdomain 2 Protein
anti-SMAD2 (human), mAb (rec.) (PAS4-G7) AG-27B-6329 Human IgG1 ELISA, ICC, PLA Human
anti-SMAD3 (human), mAb (rec.) (Phospho-T179) (SH544-IIC4) AG-27B-6330 Human IgG1 ELISA, ICC, PLA Human
anti-SMAD4 (human), mAb (rec.) (PAS7-C7) AG-27B-6331 Human IgG1 ELISA, ICC, PLA Human
anti-SMAD7 (human), mAb (rec.) (SH585-IIC4) AG-27B-6332 Human IgG1 ELISA, ICC, PLA Human
anti-Sortilin (human), mAb (rec.) (blocking) (PF) [Latozinemab] AG-27B-7000PF Human IgG1κ FUNC (Blocking) Human
anti-TcdB (Clostridioides difficile exotoxin), mAb (rec.) (VIF090-A6) AG-27B-6333 Human IgG1 ELISA, FUNC, WB Clostridioides difficile
anti-TcdB (Clostridioides difficile exotoxin), mAb (rec.) (SH1429-B1) AG-27B-6334 Human IgG1 ELISA, FUNC (strong), WB (weak) Clostridioides difficile
anti-TcdB (Clostridioides difficile exotoxin), mAb (rec.) (VIF137-E7) AG-27B-6335 Human IgG1 ELISA, FUNC, WB Clostridioides difficile
anti-α-Tubulin, mAb (rec.) (F2C) AG-27B-0005 Human IgG2λ ICC, WB Bovine, Human, Mouse
anti-β-Tubulin, mAb (rec.) (S11B)

AG-27B-0008

Human IgG2λ ELISA, ICC, IP Drosophila, Human, Monkey, Mouse, Pig, Rat
anti-Tubulin-GTP, mAb (rec.) (MB11) AG-27B-0009 Human IgG2λ ICC Drosophila, Human, Mouse, Rat

More Information



Downloadable Flyer



Recombinant Monoclonal Antibodies - Produced with No Use of Animals

• Developed from a human antibody phage display library.
• Produced in mammalian cells (CHO or HEK 293).
• Ideal for conserved antigens (which are poorly immunogenic in animals).
• For Research Purpose or Therapeutic Applications. 




 

Recombinant Antibodies Insights 2019

Download

Download PDF with Weblinks


AdipoGen Life Sciences offers the proprietary Recombinant Antibody Technology as a Service for the development of Recombinant Monoclonal Antibodies for Research Purposes or Therapeutic Applications.



Custom Recombinant Antibodies

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.